Form4insider filings, from the source

SEC Form 4 · accession 0001225208-17-015648

Edwards Lifesciences Corp · EW

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Donald E Bobo Jr.
Officer — CVP, Heart Valve Therapy
Period of report
Sep 29, 2017
Accepted (ET)
Oct 2, 2017 · 8:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001099800

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2Sep 29, 2017M5,300$44.615A24,908D
Common StockF2Sep 29, 2017S100$109.34D24,808D
Common StockF3,F2Sep 29, 2017S5,200$108.8535D19,608D
Common StockF4holding———12,461I401(k)
Common Stockholding———75,235IBy Trust

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (Right to Acquire)F2$44.615Sep 29, 2017M5,300DMay 12, 2012May 11, 2018Common Stock5,30031,800D

Explanation of responses